Potential applications of fish oils rich in omega-3 polyunsaturated fatty acids in the management of gastrointestinal cancer

Clinical Nutrition

Volumn 36, Issue 1, 2017, Pages 65-78

  Eltweri, A M ^a   Thomas, A L ^b   Metcalfe, M ^a   Calder, P C ^c,d   Dennison, A R ^a   Bowrey, D J ^a  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cancer; Docosahexaenoic acid; Eicosapentaenoic acid; Fish oil; Gastrointestinal; Inflammation

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; OMEGA 3 FATTY ACID;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; CANCER RESEARCH; CANCER STAGING; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; ESOPHAGUS CANCER; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LEAN BODY WEIGHT; METASTASIS; OVERALL SURVIVAL; PANCREAS CANCER; QUALITY OF LIFE; REVIEW; ANIMAL; DISEASE MANAGEMENT; DISEASE MODEL; EVIDENCE BASED MEDICINE; FACTUAL DATABASE; GASTROINTESTINAL TUMOR; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; DATABASES, FACTUAL; DISEASE MANAGEMENT; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; EVIDENCE-BASED MEDICINE; FATTY ACIDS, OMEGA-3; FISH OILS; GASTROINTESTINAL NEOPLASMS; HUMANS; INFLAMMATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84955560598     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2016.01.007     Document Type: Review

References (141)

1. Cancer Research UK. http://www.cancerresearchuk.org/cancer-info/cancerstats/world/mortality/, July 2014.
2. Cancer Research UK. http://www.cancerresearchuk.org/cancer-info/cancerstats/world/Incidence/, July 2014.
3. Zhang, G., Panigrahy, D., Mahakian, L.M., Yang, J., Liu, J.Y., Stephen Lee, K.S., et al. Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis. Proc Natl Acad Sci U. S. A 110:16 (2013 Apr 16), 6530–6535.
4. Sun, H., Meng, X., Han, J., Zhang, Z., Wang, B., Bai, X., et al. Anti-cancer activity of DHA on gastric cancer–an in vitro and in vivo study. Tumour Biol 34:6 (2013 Dec), 3791–3800.
5. Odenthal, J., van Heumen, B.W., Roelofs, H.M., te Morsche, R.H., Marian, B., Nagengast, F.M., et al. The influence of curcumin, quercetin, and eicosapentaenoic acid on the expression of phase II detoxification enzymes in the intestinal cell lines HT-29, Caco-2, HuTu 80, and LT97. Nutr Cancer 64:6 (2012 Aug), 856–863.
6. Lee, S.E., Lim, J.W., Kim, H., Activator protein-1 mediates docosahexaenoic acid-induced apoptosis of human gastric cancer cells. Ann N. Y Acad Sci 1171 (2009 Aug), 163–169.
7. Valentine, R.C., Valentine, D.L., Omega-3 fatty acids in cellular membranes: a unified concept. Prog Lipid Res 43:5 (2004 Sep), 383–402.
8. Calder, P.C., Omega-3 fatty acids and inflammatory processes. Nutrients 2:3 (2010 Mar), 355–374.
9. Kris-Etherton, P.M., Harris, W.S., Appel, L.J., American Heart Association, Nutrition Committee, Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106:21 (2002 Nov 19), 2747–2757.
10. Agostoni, C., Bresson, J., Fairweather-Tait, S., Flynn, A., Golly, I., Korhonen, H., et al. Sceintific opinion on the tolerable upper intake level of eicospentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA). European food safety authority (EFSA). Parma, Italy, 10(7), 2012.
11. U.S. Food and Drug Administration Centre for Food Safety and applied Nutrition, Agency response letter. GRAS notice no. GRN 000105, October 15, 2002 Available at http://www.fda.gov/ohrms/dockets/dockets/95s0316/95s-0316-rpt000343-041-appx-E-Ref-29-GRAS-vol268.pdf [accessed 29.03.04].
12. Department of Health and Human Services, US Food and Drug Administration, Substances affirmed as generally recognized as safe: menhaden oil. Fed Regist 62:No. 108 (June 5, 1997), 30751–30757 21 CFR Part 184 [Docket No. 86G-0289]. Available at http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=1997_register&docid=fr05jn97-5 [accessed June 2014].
13. Food and Nutrition Board, Institute of medicine of the national academies. Dietary fats: total fat and fatty acids. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. 2005, The National Academies Press, Washington D.C, 422–541.
14. Aggarwal, B.B., Gehlot, P., Inflammation and cancer: how friendly is the relationship for cancer patients?. Curr Opin Pharmacol 9:4 (2009 Aug), 351–369.
15. Mayer, K., Gokorsch, S., Fegbeutel, C., Hattar, K., Rosseau, S., Walmrath, D., et al. Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis. Am J Respir Crit Care Med 167:10 (2003 May 15), 1321–1328.
16. Weiss, G., Meyer, F., Matthies, B., Pross, M., Koenig, W., Lippert, H., Immunomodulation by perioperative administration of n-3 fatty acids. Br J Nutr 87:Suppl. 1 (2002 Jan), S89–S94.
17. Simopoulos, A.P., The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 56:8 (2002 Oct), 365–379.
18. Pizato, N., Bonatto, S., Yamazaki, R.K., Aikawa, J., Nogata, C., Mund, R.C., et al. Ratio of n6 to n-3 fatty acids in the diet affects tumor growth and cachexia in Walker 256 tumor-bearing rats. Nutr Cancer 53:2 (2005), 194–201.
19. Heukamp, I., Kilian, M., Gregor, J.I., Kiewert, C., Schimke, I., Kristiansen, G., et al. Impact of polyunsaturated fatty acids on hepato-pancreatic prostaglandin and leukotriene concentration in ductal pancreatic cancer – is there a correlation to tumour growth and liver metastasis?. Prostagl Leukot Essent Fat Acids 74:4 (2006 Apr), 223–233.
20. Tong, W.G., Ding, X.Z., Talamonti, M.S., Bell, R.H., Adrian, T.E., LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways. Biochem Biophys Res Commun 335:3 (2005 Sep 30), 949–956.
21. Patterson, E., Wall, R., Fitzgerald, G.F., Ross, R.P., Stanton, C., Health implications of high dietary omega-6 polyunsaturated fatty acids. J Nutr Metab, 2012, 2012, 539426.
22. Simopoulos, A.P., Omega-3 fatty acids and cancer. Indoor Built Environ 12 (2003), 405–412.
23. Hering, J., Garrean, S., Dekoj, T.R., Razzak, A., Saied, A., Trevino, J., et al. Inhibition of proliferation by omega-3 fatty acids in chemoresistant pancreatic cancer cells. Ann Surg Oncol 14:12 (2007 Dec), 3620–3628.
24. De Carlo, F., Witte, T.R., Hardman, W.E., Claudio, P.P., Omega-3 eicosapentaenoic acid decreases CD133 colon cancer stem-like cell marker expression while increasing sensitivity to chemotherapy. PLoS One, 8(7), 2013 Jul 16, e69760.
25. Granci, V., Cai, F., Lecumberri, E., Clerc, A., Dupertuis, Y.M., Pichard, C., Colon cancer cell chemosensitisation by fish oil emulsion involves apoptotic mitochondria pathway. Br J Nutr 109:7 (2013 Apr 14), 1188–1195.
26. Kuan, C.Y., Walker, T.H., Luo, P.G., Chen, C.F., Long-chain polyunsaturated fatty acids promote paclitaxel cytotoxicity via inhibition of the MDR1 gene in the human colon cancer Caco-2 cell line. J Am Coll Nutr 30:4 (2011 Aug), 265–273.
27. Sala-Vila, A., Folkes, J., Calder, P.C., The effect of three lipid emulsions differing in fatty acid composition on growth, apoptosis and cell cycle arrest in the HT-29 colorectal cancer cell line. Clin Nutr 29:4 (2010 Aug), 519–524.
28. Jordan, A., Stein, J., Effect of an omega-3 fatty acid containing lipid emulsion alone and in combination with 5-fluorouracil (5-FU) on growth of the colon cancer cell line Caco-2. Eur J Nutr 42:6 (2003 Dec), 324–331.
29. Fox, J.C., Hay, R.V., Eicosapentaenoic acid inhibits cell growth and triacylglycerol secretion in McA-RH7777 rat hepatoma cultures. Biochem J 286:Pt 1 (1992 Aug 15), 305–312.
30. Iwamoto, S., Senzaki, H., Kiyozuka, Y., Ogura, E., Takada, H., Hioki, K., et al. Effects of fatty acids on liver metastasis of ACL-15 rat colon cancer cells. Nutr Cancer 31:2 (1998), 143–150.
31. Collett, E.D., Davidson, L.A., Fan, Y.Y., Lupton, J.R., Chapkin, R.S., n-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenic Ras activation in colonocytes. Am J Physiol Cell Physiol 280:5 (2001 May), C1066–C1075.
32. Ichihara, H., Zako, K., Komizu, Y., Goto, K., Ueoka, R., Therapeutic effects of hybrid liposomes composed of phosphatidylcholine and docosahexaenoic acid on the hepatic metastasis of colon carcinoma along with apoptosis in vivo. Biol Pharm Bull 34:6 (2011), 901–905.
33. Bonatto, S.J., Oliveira, H.H., Nunes, E.A., Pequito, D., Iagher, F., Coelho, I., et al. Fish oil supplementation improves neutrophil function during cancer chemotherapy. Lipids 47:4 (2012 Apr), 383–389.
34. Silva Jde, A., Trindade, E.B., Fabre, M.E., Menegotto, V.M., Gevaerd, S., Buss Zda, S., et al. Fish oil supplement alters markers of inflammatory and nutritional status in colorectal cancer patients. Nutr Cancer 64:2 (2012), 267–273.
35. Ryan, A.M., Reynolds, J.V., Healy, L., Byrne, M., Moore, J., Brannelly, N., et al. Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial. Ann Surg 249:3 (2009 Mar), 355–363.
36. Cury-Boaventura, M.F., Torrinhas, R.S., de Godoy, A.B., Curi, R., Waitzberg, D.L., Human leukocyte death after a preoperative infusion of medium/long-chain triglyceride and fish oil parenteral emulsions: a randomized study in gastrointestinal cancer patients. JPEN J Parenter Enter Nutr 36:6 (2012 Nov), 677–684.
37. Miyata, H., Yano, M., Yasuda, T., Hamano, R., Yamasaki, M., Hou, E., et al. Randomized study of clinical effect of enteral nutrition support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancer. Clin Nutr 31:3 (2012 Jun), 330–336.
38. Jiang, Z.M., Wilmore, D.W., Wang, X.R., Wei, J.M., Zhang, Z.T., Gu, Z.Y., et al. Randomized clinical trial of intravenous soybean oil alone versus soybean oil plus fish oil emulsion after gastrointestinal cancer surgery. Br J Surg 97:6 (2010 Jun), 804–809.
39. Aiko, S., Yoshizumi, Y., Ishizuka, T., Horio, T., Sakano, T., Kumano, I., et al. Enteral immuno-enhanced diets with arginine are safe and beneficial for patients early after esophageal cancer surgery. Dis Esophagus 21:7 (2008), 619–627.
40. Liang, B., Wang, S., Ye, Y.J., Yang, X.D., Wang, Y.L., Qu, J., et al. Impact of postoperative omega-3 fatty acid-supplemented parenteral nutrition on clinical outcomes and immunomodulations in colorectal cancer patients. World J Gastroenterol 14:15 (2008 Apr 21), 2434–2439.
41. Chen, D.W., Wei Fei, Z., Zhang, Y.C., Ou, J.M., Xu, J., Role of enteral immunonutrition in patients with gastric carcinoma undergoing major surgery. Asian J Surg 28:2 (2005 Apr), 121–124.
42. Aiko, S., Yoshizumi, Y., Tsuwano, S., Shimanouchi, M., Sugiura, Y., Maehara, T., The effects of immediate enteral feeding with a formula containing high levels of omega-3 fatty acids in patients after surgery for esophageal cancer. JPEN J Parenter Enter Nutr 29:3 (2005 May-Jun), 141–147.
43. Farreras, N., Artigas, V., Cardona, D., Rius, X., Trias, M., Gonzalez, J.A., Effect of early postoperative enteral immunonutrition on wound healing in patients undergoing surgery for gastric cancer. Clin Nutr 24:1 (2005 Feb), 55–65.
44. Heller, A.R., Rossel, T., Gottschlich, B., Tiebel, O., Menschikowski, M., Litz, R.J., et al. Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Int J Cancer 111:4 (2004 Sep 10), 611–616.
45. Braga, M., Gianotti, L., Vignali, A., Carlo, V.D., Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery 132:5 (2002 Nov), 805–814.
46. Wu, G.H., Zhang, Y.W., Wu, Z.H., Modulation of postoperative immune and inflammatory response by immune-enhancing enteral diet in gastrointestinal cancer patients. World J Gastroenterol 7:3 (2001 Jun), 357–362.
47. Senkal, M., Zumtobel, V., Bauer, K.H., Marpe, B., Wolfram, G., Frei, A., et al. Outcome and cost-effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery: a prospective randomized study. Arch Surg 134:12 (1999 Dec), 1309–1316.
48. Kenler, A.S., Swails, W.S., Driscoll, D.F., DeMichele, S.J., Daley, B., Babineau, T.J., et al. Early enteral feeding in postsurgical cancer patients. Fish oil structured lipid-based polymeric formula versus a standard polymeric formula. Ann Surg 223:3 (1996 Mar), 316–333.
49. Kemen, M., Senkal, M., Homann, H.H., Mumme, A., Dauphin, A.K., Baier, J., et al. Early postoperative enteral nutrition with arginine-omega-3 fatty acids and ribonucleic acid-supplemented diet versus placebo in cancer patients: an immunologic evaluation of Impact. Crit Care Med 23:4 (1995 Apr), 652–659.
50. Barber, M.D., Preston, T., McMillan, D.C., Slater, C., Ross, J.A., Fearon, K.C., Modulation of the liver export protein synthetic response to feeding by an n-3 fatty-acid-enriched nutritional supplement is associated with anabolism in cachectic cancer patients. Clin Sci (Lond) 106:4 (2004 Apr), 359–364.
51. Barber, M.D., Ross, J.A., Voss, A.C., Tisdale, M.J., Fearon, K.C., The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer 81:1 (1999 Sep), 80–86.
52. Barber, M.D., McMillan, D.C., Preston, T., Ross, J.A., Fearon, K.C., Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement. Clin Sci (Lond) 98:4 (2000 Apr), 389–399.
53. Gogos, C.A., Ginopoulos, P., Salsa, B., Apostolidou, E., Zoumbos, N.C., Kalfarentzos, F., Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer 82:2 (1998 Jan 15), 395–402.
54. Persson, C., Glimelius, B., Ronnelid, J., Nygren, P., Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer: a randomized pilot study. Nutrition 21:2 (2005 Feb), 170–178.
55. Moses, A.W., Slater, C., Preston, T., Barber, M.D., Fearon, K.C., Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 90:5 (2004 Mar 8), 996–1002.
56. Wigmore, S.J., Barber, M.D., Ross, J.A., Tisdale, M.J., Fearon, K.C., Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer 36:2 (2000), 177–184.
57. Trabal, J., Leyes, P., Forga, M., Maurel, J., Potential usefulness of an EPA-enriched nutritional supplement on chemotherapy tolerability in cancer patients without overt malnutrition. Nutr Hosp 25:5 (2010 Sep-Oct), 736–740.
58. Read, J.A., Beale, P.J., Volker, D.H., Smith, N., Childs, A., Clarke, S.J., Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial. Support Care Cancer 15:3 (2007 Mar), 301–307.
59. Ma, C.J., Sun, L.C., Chen, F.M., Lu, C.Y., Shih, Y.L., Tsai, H.L., et al. A double-blind randomized study comparing the efficacy and safety of a composite vs a conventional intravenous fat emulsion in postsurgical gastrointestinal tumor patients. Nutr Clin Pract 27:3 (2012 Jun), 410–415.
60. de Miranda Torrinhas, R.S., Santana, R., Garcia, T., Cury-Boaventura, M.F., Sales, M.M., Curi, R., et al. Parenteral fish oil as a pharmacological agent to modulate post-operative immune response: a randomized, double-blind, and controlled clinical trial in patients with gastrointestinal cancer. Clin Nutr 32:4 (2013 Aug), 503–510.
61. Klek, S., Kulig, J., Szczepanik, A.M., Jedrys, J., Kolodziejczyk, P., The clinical value of parenteral immunonutrition in surgical patients. Acta Chir Belg 105:2 (2005 Apr), 175–179.
62. Jones, R.J., Hawkins, R.E., Eatock, M.M., Ferry, D.R., Eskens, F.A., Wilke, H., et al. A phase II open-label study of DHA-paclitaxel (Taxoprexin) by 2-h intravenous infusion in previously untreated patients with locally advanced or metastatic gastric or oesophageal adenocarcinoma. Cancer Chemother Pharmacol 61:3 (2008 Mar), 435–441.
63. Sultan, J., Griffin, S.M., Di Franco, F., Kirby, J.A., Shenton, B.K., Seal, C.J., et al. Randomized clinical trial of omega-3 fatty acid-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing oesophagogastric cancer surgery. Br J Surg 99:3 (2012 Mar), 346–355.
64. Makay, O., Kaya, T., Firat, O., Sozbilen, M., Caliskan, C., Gezer, G., et al. omega-3 fatty acids have no impact on serum lactate levels after major gastric cancer surgery. JPEN J Parenter Enter Nutr 35:4 (2011 Jul), 488–492.
65. Fukui, M., Kang, K.S., Okada, K., Zhu, B.T., EPA, an omega-3 fatty acid, induces apoptosis in human pancreatic cancer cells: role of ROS accumulation, caspase-8 activation, and autophagy induction. J Cell Biochem 114:1 (2013 Jan), 192–203.
66. D'Eliseo, D., Manzi, L., Merendino, N., Velotti, F., Docosahexaenoic acid inhibits invasion of human RT112 urinary bladder and PT45 pancreatic carcinoma cells via down-modulation of granzyme B expression. J Nutr Biochem 23:5 (2012 May), 452–457.
67. Hawkins, R.A., Sangster, K., Arends, M.J., Apoptotic death of pancreatic cancer cells induced by polyunsaturated fatty acids varies with double bond number and involves an oxidative mechanism. J Pathol 185:1 (1998 May), 61–70.
68. Lai, P.B., Ross, J.A., Fearon, K.C., Anderson, J.D., Carter, D.C., Cell cycle arrest and induction of apoptosis in pancreatic cancer cells exposed to eicosapentaenoic acid in vitro. Br J Cancer 74:9 (1996 Nov), 1375–1383.
69. Falconer, J.S., Ross, J.A., Fearon, K.C., Hawkins, R.A., O'Riordain, M.G., Carter, D.C., Effect of eicosapentaenoic acid and other fatty acids on the growth in vitro of human pancreatic cancer cell lines. Br J Cancer 69:5 (1994 May), 826–832.
70. Fenton, J.I., McCaskey, S.J., Curcumin and docosahexaenoic acid block insulin-induced colon carcinoma cell proliferation. Prostagl Leukot Essent Fat Acids 88:3 (2013 Mar), 219–226.
71. Fasano, E., Serini, S., Piccioni, E., Toesca, A., Monego, G., Cittadini, A.R., et al. DHA induces apoptosis by altering the expression and cellular location of GRP78 in colon cancer cell lines. Biochim Biophys Acta 1822:11 (2012 Nov), 1762–1772.
72. Manda, K., Kriesen, S., Hildebrandt, G., Fietkau, R., Klautke, G., Omega-3 fatty acid supplementation in cancer therapy: does eicosapentanoic acid influence the radiosensitivity of tumor cells?. Strahlenther Onkol 187:2 (2011 Feb), 127–134.
73. Slagsvold, J.E., Pettersen, C.H., Storvold, G.L., Follestad, T., Krokan, H.E., Schonberg, S.A., DHA alters expression of target proteins of cancer therapy in chemotherapy resistant SW620 colon cancer cells. Nutr Cancer 62:5 (2010), 611–621.
74. Rogers, K.R., Kikawa, K.D., Mouradian, M., Hernandez, K., McKinnon, K.M., Ahwah, S.M., et al. Docosahexaenoic acid alters epidermal growth factor receptor-related signaling by disrupting its lipid raft association. Carcinogenesis 31:9 (2010 Sep), 1523–1530.
75. Habermann, N., Schon, A., Lund, E.K., Glei, M., Fish fatty acids alter markers of apoptosis in colorectal adenoma and adenocarcinoma cell lines but fish consumption has no impact on apoptosis-induction ex vivo. Apoptosis 15:5 (2010 May), 621–630.
76. Hawcroft, G., Loadman, P.M., Belluzzi, A., Hull, M.A., Effect of eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signaling in human colorectal cancer cells. Neoplasia 12:8 (2010 Aug), 618–627.
77. Dommels, Y.E., Alink, G.M., Linssen, J.P., van Ommen, B., Effects of n-6 and n-3 polyunsaturated fatty acids on gap junctional intercellular communication during spontaneous differentiation of the human colon adenocarcinoma cell line Caco-2. Nutr Cancer 42:1 (2002), 125–130.
78. Kumamoto-Yonezawa, Y., Sasaki, R., Ota, Y., Suzuki, Y., Fukushima, S., Hada, T., et al. Cell cycle arrest triggered by conjugated eicosapentaenoic acid occurs through several mechanisms including G1 checkpoint activation by induced RPA and ATR expression. Biochim Biophys Acta 1790:5 (2009 May), 339–346.
79. Danbara, N., Yuri, T., Tsujita-Kyutoku, M., Sato, M., Senzaki, H., Takada, H., et al. Conjugated docosahexaenoic acid is a potent inducer of cell cycle arrest and apoptosis and inhibits growth of colo 201 human colon cancer cells. Nutr Cancer 50:1 (2004), 71–79.
80. Habbel, P., Weylandt, K.H., Lichopoj, K., Nowak, J., Purschke, M., Wang, J.D., et al. Docosahexaenoic acid suppresses arachidonic acid-induced proliferation of LS-174T human colon carcinoma cells. World J Gastroenterol 15:9 (2009 Mar 7), 1079–1084.
81. Tang, F.Y., Cho, H.J., Pai, M.H., Chen, Y.H., Concomitant supplementation of lycopene and eicosapentaenoic acid inhibits the proliferation of human colon cancer cells. J Nutr Biochem 20:6 (2009 Jun), 426–434.
82. Hossain, Z., Hosokawa, M., Takahashi, K., Growth inhibition and induction of apoptosis of colon cancer cell lines by applying marine phospholipid. Nutr Cancer 61:1 (2009), 123–130.
83. Jakobsen, C.H., Storvold, G.L., Bremseth, H., Follestad, T., Sand, K., Mack, M., et al. DHA induces ER stress and growth arrest in human colon cancer cells: associations with cholesterol and calcium homeostasis. J Lipid Res 49:10 (2008 Oct), 2089–2100.
84. Allred, C.D., Talbert, D.R., Southard, R.C., Wang, X., Kilgore, M.W., PPARgamma1 as a molecular target of eicosapentaenoic acid in human colon cancer (HT-29) cells. J Nutr 138:2 (2008 Feb), 250–256.
85. Toit-Kohn, J.L., Louw, L., Engelbrecht, A.M., Docosahexaenoic acid induces apoptosis in colorectal carcinoma cells by modulating the PI3 kinase and p38 MAPK pathways. J Nutr Biochem 20:2 (2009 Feb), 106–114.
86. Goto, K., Tanaka, Y., Matsumoto, Y., Ueoka, R., Induction of apoptosis of human tumor cells by hybrid liposomes including docosahexaenoic acid. Bioorg Med Chem Lett 18:6 (2008 Mar 15), 1880–1883.
87. Kato, T., Kolenic, N., Pardini, R.S., Docosahexaenoic acid (DHA), a primary tumor suppressive omega-3 fatty acid, inhibits growth of colorectal cancer independent of p53 mutational status. Nutr Cancer 58:2 (2007), 178–187.
88. Calviello, G., Resci, F., Serini, S., Piccioni, E., Toesca, A., Boninsegna, A., et al. Docosahexaenoic acid induces proteasome-dependent degradation of beta-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2. Carcinogenesis 28:6 (2007 Jun), 1202–1209.
89. Tsuzuki, T., Kambe, T., Shibata, A., Kawakami, Y., Nakagawa, K., Miyazawa, T., Conjugated EPA activates mutant p53 via lipid peroxidation and induces p53-dependent apoptosis in DLD-1 colorectal adenocarcinoma human cells. Biochim Biophys Acta 1771:1 (2007 Jan), 20–30.
90. Calviello, G., Di Nicuolo, F., Serini, S., Piccioni, E., Boninsegna, A., Maggiano, N., et al. Docosahexaenoic acid enhances the susceptibility of human colorectal cancer cells to 5-fluorouracil. Cancer Chemother Pharmacol 55:1 (2005 Jan), 12–20.
91. Narayanan, B.A., Narayanan, N.K., Desai, D., Pittman, B., Reddy, B.S., Effects of a combination of docosahexaenoic acid and 1,4-phenylene bis(methylene) selenocyanate on cyclooxygenase 2, inducible nitric oxide synthase and beta-catenin pathways in colon cancer cells. Carcinogenesis 25:12 (2004 Dec), 2443–2449.
92. Vaculova, A., Hofmanova, J., Andera, L., Kozubik, A., TRAIL and docosahexaenoic acid cooperate to induce HT-29 colon cancer cell death. Cancer Lett 229:1 (2005 Nov 8), 43–48.
93. Calviello, G., Di Nicuolo, F., Gragnoli, S., Piccioni, E., Serini, S., Maggiano, N., et al. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. Carcinogenesis 25:12 (2004 Dec), 2303–2310.
94. Moonen, H.J., Dommels, Y.E., van Zwam, M., van Herwijnen, M.H., Kleinjans, J.C., Alink, G.M., et al. Effects of polyunsaturated fatty acids on prostaglandin synthesis and cyclooxygenase-mediated DNA adduct formation by heterocyclic aromatic amines in human adenocarcinoma colon cells. Mol Carcinog 40:3 (2004 Jul), 180–188.
95. Swamy, M.V., Cooma, I., Patlolla, J.M., Simi, B., Reddy, B.S., Rao, C.V., Modulation of cyclooxygenase-2 activities by the combined action of celecoxib and decosahexaenoic acid: novel strategies for colon cancer prevention and treatment. Mol Cancer Ther 3:2 (2004 Feb), 215–221.
96. Narayanan, B.A., Narayanan, N.K., Simi, B., Reddy, B.S., Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells. Cancer Res 63:5 (2003 Mar 1), 972–979.
97. Dommels, Y.E., Haring, M.M., Keestra, N.G., Alink, G.M., van Bladeren, P.J., van Ommen, B., The role of cyclooxygenase in n-6 and n-3 polyunsaturated fatty acid mediated effects on cell proliferation, PGE(2) synthesis and cytotoxicity in human colorectal carcinoma cell lines. Carcinogenesis 24:3 (2003 Mar), 385–392.
98. Chen, Z.Y., Istfan, N.W., Docosahexaenoic acid is a potent inducer of apoptosis in HT-29 colon cancer cells. Prostagl Leukot Essent Fat Acids 63:5 (2000 Nov), 301–308.
99. Jiang, W.G., Hiscox, S., Bryce, R.P., Horrobin, D.F., Mansel, R.E., The effects of n-6 polyunsaturated fatty acids on the expression of nm-23 in human cancer cells. Br J Cancer 77:5 (1998 Mar), 731–738.
100. Mengeaud, V., Nano, J.L., Fournel, S., Rampal, P., Effects of eicosapentaenoic acid, gamma-linolenic acid and prostaglandin E1 on three human colon carcinoma cell lines. Prostagl Leukot Essent Fat Acids 47:4 (1992 Dec), 313–319.
101. Wu, M.H., Tsai, Y.T., Hua, K.T., Chang, K.C., Kuo, M.L., Lin, M.T., Eicosapentaenoic acid and docosahexaenoic acid inhibit macrophage-induced gastric cancer cell migration by attenuating the expression of matrix metalloproteinase 10. J Nutr Biochem 23:11 (2012 Nov), 1434–1439.
102. Zhuo, Z., Zhang, L., Mu, Q., Lou, Y., Gong, Z., Shi, Y., et al. The effect of combination treatment with docosahexaenoic acid and 5-fluorouracil on the mRNA expression of apoptosis-related genes, including the novel gene BCL2L12, in gastric cancer cells. Vitro Cell Dev Biol Anim 45:1–2 (2009 Jan-Feb), 69–74.
103. Lim, K., Han, C., Dai, Y., Shen, M., Wu, T., Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2. Mol Cancer Ther 8:11 (2009 Nov), 3046–3055.
104. Chi, T.Y., Chen, G.G., Lai, P.B., Eicosapentaenoic acid induces Fas-mediated apoptosis through a p53-dependent pathway in hepatoma cells. Cancer J 10:3 (2004 May-Jun), 190–200.
105. Kansal, S., Negi, A.K., Bhatnagar, A., Agnihotri, N., Ras signaling pathway in the chemopreventive action of different ratios of fish oil and corn oil in experimentally induced colon carcinogenesis. Nutr Cancer 64:4 (2012), 559–568.
106. Cho, Y., Turner, N.D., Davidson, L.A., Chapkin, R.S., Carroll, R.J., Lupton, J.R., A chemoprotective fish oil/pectin diet enhances apoptosis via Bcl-2 promoter methylation in rat azoxymethane-induced carcinomas. Exp Biol Med (Maywood) 237:12 (2012 Dec), 1387–1393.
107. Hawcroft, G., Volpato, M., Marston, G., Ingram, N., Perry, S.L., Cockbain, A.J., et al. The omega-3 polyunsaturated fatty acid eicosapentaenoic acid inhibits mouse MC-26 colorectal cancer cell liver metastasis via inhibition of PGE2-dependent cell motility. Br J Pharmacol 166:5 (2012 Jul), 1724–1737.
108. Sarotra, P., Kansal, S., Sandhir, R., Agnihotri, N., Chemopreventive effect of different ratios of fish oil and corn oil on prognostic markers, DNA damage and cell cycle in colon carcinogenesis. Eur J Cancer Prev 21:2 (2012 Mar), 147–154.
109. Shah, M.S., Schwartz, S.L., Zhao, C., Davidson, L.A., Zhou, B., Lupton, J.R., et al. Integrated microRNA and mRNA expression profiling in a rat colon carcinogenesis model: effect of a chemo-protective diet. Physiol Genomics 43:10 (2011 May 1), 640–654.
110. Cho, Y., Kim, H., Turner, N.D., Mann, J.C., Wei, J., Taddeo, S.S., et al. A chemoprotective fish oil- and pectin-containing diet temporally alters gene expression profiles in exfoliated rat colonocytes throughout oncogenesis. J Nutr 141:6 (2011 Jun), 1029–1035.
111. Sarotra, P., Sharma, G., Kansal, S., Negi, A.K., Aggarwal, R., Sandhir, R., et al. Chemopreventive effect of different ratios of fish oil and corn oil in experimental colon carcinogenesis. Lipids 45:9 (2010 Sep), 785–798.
112. Moreira, A.P., Sabarense, C.M., Dias, C.M., Lunz, W., Natali, A.J., Gloria, M.B., et al. Fish oil ingestion reduces the number of aberrant crypt foci and adenoma in 1,2-dimethylhydrazine-induced colon cancer in rats. Braz J Med Biol Res 42:12 (2009 Dec), 1167–1172.
113. Hong, M.Y., Chapkin, R.S., Davidson, L.A., Turner, N.D., Morris, J.S., Carroll, R.J., et al. Fish oil enhances targeted apoptosis during colon tumor initiation in part by downregulating Bcl-2. Nutr Cancer 46:1 (2003), 44–51.
114. Strouch, M.J., Ding, Y., Salabat, M.R., Melstrom, L.G., Adrian, K., Quinn, C., et al. A high omega-3 fatty acid diet mitigates murine pancreatic precancer development. J Surg Res 165:1 (2011 Jan), 75–81.
115. Bathen, T.F., Holmgren, K., Lundemo, A.G., Hjelstuen, M.H., Krokan, H.E., Gribbestad, I.S., et al. Omega-3 fatty acids suppress growth of SW620 human colon cancer xenografts in nude mice. Anticancer Res 28:6A (2008 Nov-Dec), 3717–3723.
116. Fukunaga, K., Hossain, Z., Takahashi, K., Marine phosphatidylcholine suppresses 1,2-dimethylhydrazine-induced colon carcinogenesis in rats by inducing apoptosis. Nutr Res 28:9 (2008 Sep), 635–640.
117. Gutt, C.N., Brinkmann, L., Mehrabi, A., Fonouni, H., Muller-Stich, B.P., Vetter, G., et al. Dietary omega-3-polyunsaturated fatty acids prevent the development of metastases of colon carcinoma in rat liver. Eur J Nutr 46:5 (2007 Aug), 279–285.
118. Davidson, L.A., Nguyen, D.V., Hokanson, R.M., Callaway, E.S., Isett, R.B., Turner, N.D., et al. Chemopreventive n-3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation and progression in the rat. Cancer Res 64:18 (2004 Sep 15), 6797–6804.
119. Whitehouse, A.S., Smith, H.J., Drake, J.L., Tisdale, M.J., Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid. Cancer Res 61:9 (2001 May 1), 3604–3609.
120. Sauer, L.A., Dauchy, R.T., Blask, D.E., Mechanism for the antitumor and anticachectic effects of n-3 fatty acids. Cancer Res 60:18 (2000 Sep 15), 5289–5295.
121. Griffini, P., Fehres, O., Klieverik, L., Vogels, I.M., Tigchelaar, W., Smorenburg, S.M., et al. Dietary omega-3 polyunsaturated fatty acids promote colon carcinoma metastasis in rat liver. Cancer Res 58:15 (1998 Aug 1), 3312–3319.
122. Singh, J., Hamid, R., Reddy, B.S., Dietary fish oil inhibits the expression of farnesyl protein transferase and colon tumor development in rodents. Carcinogenesis 19:6 (1998 Jun), 985–989.
123. Jiang, Y.H., Lupton, J.R., Chapkin, R.S., Dietary fish oil blocks carcinogen-induced down-regulation of colonic protein kinase C isozymes. Carcinogenesis 18:2 (1997 Feb), 351–357.
124. Takahashi, M., Fukutake, M., Isoi, T., Fukuda, K., Sato, H., Yazawa, K., et al. Suppression of azoxymethane-induced rat colon carcinoma development by a fish oil component, docosahexaenoic acid (DHA). Carcinogenesis 18:7 (1997 Jul), 1337–1342.
125. Singh, J., Hamid, R., Reddy, B.S., Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer. Cancer Res 57:2 (1997 Jan 15), 253–258.
126. Iigo, M., Nakagawa, T., Ishikawa, C., Iwahori, Y., Asamoto, M., Yazawa, K., et al. Inhibitory effects of docosahexaenoic acid on colon carcinoma 26 metastasis to the lung. Br J Cancer 75:5 (1997), 650–655.
127. Suzuki, I., Iigo, M., Ishikawa, C., Kuhara, T., Asamoto, M., Kunimoto, T., et al. Inhibitory effects of oleic and docosahexaenoic acids on lung metastasis by colon-carcinoma-26 cells are associated with reduced matrix metalloproteinase-2 and -9 activities. Int J Cancer 73:4 (1997 Nov 14), 607–612.
128. Singh, J., Hamid, R., Reddy, B.S., Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res 57:16 (1997 Aug 15), 3465–3470.
129. Nagano, T., Fujita, H., Tanaka, T., Matono, S., Murata, K., Ishibashi, N., et al. Randomized controlled trial comparing antioxidant-enriched enteral nutrition with immune-enhancing enteral nutrition after esophagectomy for cancer: a pilot study. Surg Today 43:11 (2013 Nov), 1240–1249.
130. Nakamura, M., Iwahashi, M., Takifuji, K., Nakamori, M., Naka, T., Ishida, K., et al. Optimal dose of preoperative enteral immunonutrition for patients with esophageal cancer. Surg Today 39:10 (2009), 855–860.
131. Okamoto, Y., Okano, K., Izuishi, K., Usuki, H., Wakabayashi, H., Suzuki, Y., Attenuation of the systemic inflammatory response and infectious complications after gastrectomy with preoperative oral arginine and omega-3 fatty acids supplemented immunonutrition. World J Surg 33:9 (2009 Sep), 1815–1821.
132. Takeuchi, H., Ikeuchi, S., Kawaguchi, Y., Kitagawa, Y., Isobe, Y., Kubochi, K., et al. Clinical significance of perioperative immunonutrition for patients with esophageal cancer. World J Surg 31:11 (2007 Nov), 2160–2167.
133. Helminen, H., Raitanen, M., Kellosalo, J., Immunonutrition in elective gastrointestinal surgery patients. Scand J Surg 96:1 (2007), 46–50.
134. Braga, M., Gianotti, L., Nespoli, L., Radaelli, G., Di Carlo, V., Nutritional approach in malnourished surgical patients: a prospective randomized study. Arch Surg 137:2 (2002 Feb), 174–180.
135. Gee, J.M., Watson, M., Matthew, J.A., Rhodes, M., Speakman, C.J., Stebbings, W.S., et al. Consumption of fish oil leads to prompt incorporation of eicosapentaenoic acid into colonic mucosa of patients prior to surgery for colorectal cancer, but has no detectable effect on epithelial cytokinetics. J Nutr 129:10 (1999 Oct), 1862–1865.
136. Daly, J.M., Lieberman, M.D., Goldfine, J., Shou, J., Weintraub, F., Rosato, E.F., et al. Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery 112:1 (1992 Jul), 56–67.
137. Fearon, K.C., Von Meyenfeldt, M.F., Moses, A.G., Van Geenen, R., Roy, A., Gouma, D.J., et al. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 52:10 (2003 Oct), 1479–1486.
138. Wigmore, S.J., Ross, J.A., Falconer, J.S., Plester, C.E., Tisdale, M.J., Carter, D.C., et al. The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition 12:1 Suppl (1996 Jan), S27–S30.
139. Gomez-Candela, C., Villarino Sanz, M., Horrisberger, A., Loria Kohen, V., Bermejo, L.M., Zamora Aunon, P., Efficacy evaluation of an oral powder supplement enriched with eicosapentaenoic acid in cancer patients. Nutr Hosp 26:6 (2011 Nov-Dec), 1385–1393.
140. Serhan, C.N., Hong, S., Gronert, K., Colgan, S.P., Devchand, P.R., Mirick, G., et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 196:8 (2002 Oct 21), 1025–1037.
141. Balvers, M.G., Verhoeckx, K.C., Bijlsma, S., Rubingh, C.M., Meijerink, J., Wortelboer, H.M., et al. Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues. Metabolomics 8:6 (2012 Dec), 1130–1147.